within Pharmacolibrary.Drugs.ATC.B;

model B02BA01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 3.666666666666667e-06,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00014000000000000001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00065,
    k12             = 0.46,
    k21             = 0.46
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>B02BA01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Phytomenadione (vitamin K1) is a fat-soluble vitamin used primarily to prevent and treat vitamin K deficiency bleeding, notably in newborns and in conditions of hypoprothrombinemia due to coumarin anticoagulants or other causes. It is approved and widely used today in clinical medicine.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Watt, BE, et al., &amp; Vale, JA (2005). Anticoagulant rodenticides. <i>Toxicological reviews</i> 24(4) 259–269. DOI:<a href=&quot;https://doi.org/10.2165/00139709-200524040-00005&quot;>10.2165/00139709-200524040-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16499407/&quot;>https://pubmed.ncbi.nlm.nih.gov/16499407</a></p></li><li><p>Marinova, M, et al., &amp; Oldenburg, J (2013). VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation. <i>European journal of clinical pharmacology</i> 69(3) 467–475. DOI:<a href=&quot;https://doi.org/10.1007/s00228-012-1362-y&quot;>10.1007/s00228-012-1362-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22864379/&quot;>https://pubmed.ncbi.nlm.nih.gov/22864379</a></p></li><li><p>Soedirman, JR, et al., &amp; Grüter, J (1996). Pharmacokinetics and tolerance of intravenous and intramuscular phylloquinone (vitamin K1) mixed micelles formulation. <i>British journal of clinical pharmacology</i> 41(6) 517–523. DOI:<a href=&quot;https://doi.org/10.1046/j.1365-2125.1996.03847.x&quot;>10.1046/j.1365-2125.1996.03847.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8799516/&quot;>https://pubmed.ncbi.nlm.nih.gov/8799516</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end B02BA01;
